Clinical Research: IRB

COVID-19

Effective March 27, 2020

Temporary guidelines related to COVID-19 protocol revisions

Due to the unprecedented COVID-19 emergency, investigators may be required to alter their protocols in ways to minimize the spread of this virus. The following outlines when or if the IRB needs to be notified.

http://irb.ufl.edu/wp-content/uploads/Temporary-Guideline-COVID-19-Related-Protocol-Revisions.pdf

Effective March 24, 2020

CONDUCTING APPROVED HUMAN SUBJECT RESEARCH DURING THE COVID-19 PANDEMIC

Effective immediately, the University will use the following guidelines when assessing whether specific human subject research projects may continue at UF. These guidelines are for human subject research only, pertinent only during the current COVID-19 epidemic, and will be in place until removed by the UF Vice President for Research. Since this crisis is fluid, these recommendations may change over time.

https://research.ufl.edu/wp-content/uploads/humanresearchcovid.pdf

Effective December 5, 2019, UF IRB to require GCP training for all investigators on NIH-funded clinical trials

     - All PIs and SS engaged in NIH-funded clinical trials (biomedical or behavioral) must provide documentation that GCP training has been completed to the IRB.

     How do researchers/staff provide documentation of GCP training completion? 

Please email the following to  ufirb-l@lists.ufl.edu:

1. Your full name (no nicknames)

2. Your UFID #

3. A copy of the actual GCP completion certificate

*Once all of the above are received, IRB staff will enter your training records into myTraining. It will then take 48 hours for the training to process in the system. Please budget this time in your submission schedule.* 

     - If you have any questions, contact the IRB office at 362 273-9600 or ufirb-l@lists.ufl.edu 

myIRB has been upgraded.

    - A new researcher manual is available at: http://irb.ufl.edu/wp-content/uploads/Researcher-Manual_FINAL.pdf